ストックスクリーナーアプリを入手
20.93
0.76%
-0.16
Oculis Holding Ag (OCS) 最新ニュース
What recovery options are there for Oculis Holding AGOptions Play & Weekly Breakout Watchlists - newser.com
Oculis Holding AG Equity Warrant’s volatility index tracking explained2025 Support & Resistance & High Conviction Buy Zone Picks - newser.com
What’s the recovery path for long term holders of Oculis Holding AGPortfolio Value Summary & Daily Entry Point Alerts - newser.com
Using data tools to time your Oculis Holding AG Equity Warrant exitGlobal Markets & Expert Approved Trade Ideas - newser.com
Live market analysis of Oculis Holding AG Equity WarrantJuly 2025 Sector Moves & AI Enhanced Trading Alerts - newser.com
Why Oculis Holding AG Equity Warrant stock could outperform in 2025Profit Target & AI Based Trade Execution Alerts - newser.com
Leading vs lagging indicators on Oculis Holding AG performanceEarnings Risk Report & Precise Trade Entry Recommendations - newser.com
Will Oculis Holding AG stock gain from strong economyWeekly Stock Analysis & Community Consensus Picks - newser.com
Chardan Capital Issues Positive Estimate for Oculis Earnings - MarketBeat
Risk adjusted return profile for Oculis Holding AG analyzedPrice Action & Low Drawdown Momentum Ideas - newser.com
Using RSI to spot recovery in Oculis Holding AG Equity Warrant2025 Trading Recap & Low Risk High Reward Ideas - newser.com
Will Oculis Holding AG Equity Warrant price bounce be sustainableJuly 2025 Spike Watch & Weekly Market Pulse Alerts - newser.com
Sentiment analysis tools applied to Oculis Holding AGMarket Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
Why Oculis Holding AG (CR5) stock is favored by hedge fundsIPO Watch & Long-Term Capital Growth Strategies - newser.com
Chart based analysis of Oculis Holding AG trendsJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Oculis Holding AG (OCS) Soars 6.3%: Is Further Upside Left in the Stock? - Nasdaq
Oculis' (OCS) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Is Oculis Holding AG Equity Warrant stock entering bullish territoryJuly 2025 Drop Watch & Verified Technical Trade Signals - newser.com
Price action breakdown for Oculis Holding AG Equity WarrantEarnings Recap Summary & Consistent Return Investment Signals - newser.com
Will Oculis Holding AG (CR5) stock benefit from sector leadershipIPO Watch & Accurate Technical Buy Alerts - newser.com
Chardan Capital Forecasts Strong Price Appreciation for Oculis (NASDAQ:OCS) Stock - Defense World
Oculis Holding AG Equity Warrant stock momentum explainedFed Meeting & Daily Growth Stock Tips - newser.com
What recovery options are there for Oculis Holding AG Equity Warrant - newser.com
What to expect from Oculis Holding AG in the next 30 daysTrade Signal Summary & Smart Swing Trading Alerts - newser.com
Can volume confirm reversal in Oculis Holding AG2025 Price Momentum & Reliable Trade Execution Plans - newser.com
Applying chart zones and confluence areas to Oculis Holding AG Equity Warrant2025 Market WrapUp & Scalable Portfolio Growth Ideas - newser.com
Oculis (NASDAQ:OCS) Sees Large Volume Increase Following Analyst Upgrade - Defense World
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - GlobeNewswire
Chardan Research Adjusts Oculis Holding AG Price Target to $51 From $33, Maintains Buy Rating - MarketScreener
Oculis (NASDAQ:OCS) Price Target Raised to $51.00 - MarketBeat
Chardan Capital Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - Defense World
Oculis (NASDAQ:OCS) Sees Unusually-High Trading Volume After Analyst Upgrade - MarketBeat
Oculis (NASDAQ:OCS) Given New $36.00 Price Target at HC Wainwright - MarketBeat
HC Wainwright & Co. Maintains Oculis Holding (OCS) Buy Recommendation - Nasdaq
Oculis stock price target raised to $36 from $33 at H.C. Wainwright - Investing.com
Oculis to launch PIONEER trials for privosegtor in acute optic neuritis and NAION - Ophthalmology Times
Oculis Advances Privosegtor into Registrational Trials for Neuro-Ophthalmology - TipRanks
Does Oculis Holding AG Equity Warrant show high probability of reboundJuly 2025 Rallies & Community Supported Trade Ideas - newser.com
Reversal indicators forming on Oculis Holding AG Equity Warrant stockEarnings Risk Summary & Weekly High Conviction Trade Ideas - newser.com
Oculis Advances Privosegtor Into Registrational Trials for Neuroprotective Therapy - MarketScreener
Will Oculis Holding AG Equity Warrant bounce back from current supportJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - newser.com
Why retail traders accumulate Oculis Holding AG (CR5) stockJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Can trapped investors hope for a rebound in Oculis Holding AG Equity WarrantJuly 2025 Recap & Pattern Based Trade Signal System - newser.com
Oculis Accelerates Privosegtor into Registrational Trials in Acute Optic Neuritis, Pioneering the Path for a Potential First-in-class Neuroprotective Therapy - The Manila Times
Oculis Advances Privosegtor into Pivotal Development for Acute Optic Neuritis and NAION Following Positive FDA Meeting - Quiver Quantitative
Will Oculis Holding AG (CR5) stock sustain bullish trend into 2025Trade Risk Report & Risk Adjusted Buy and Sell Alerts - newser.com
3 pivotal trials: Oculis launches PIONEER program for Privosegtor after positive FDA meeting - Stock Titan
Brokerages Set Oculis Holding AG (NASDAQ:OCS) PT at $35.75 - Defense World
What machine learning models say about Oculis Holding AG2025 Top Gainers & Free High Return Stock Watch Alerts - newser.com
Published on: 2025-10-05 06:40:04 - newser.com
Published on: 2025-10-05 05:35:30 - newser.com
Will Oculis Holding AG rebound enough to break evenGap Down & Daily Risk Controlled Trade Plans - newser.com
Multi factor analysis applied to Oculis Holding AGMarket Sentiment Review & Risk Controlled Daily Trade Plans - newser.com
1.12%
大文字化:
|
ボリューム (24 時間):